Small-Molecule Modulation Of The Circadian Clock In Cancer And Aging
Our bodies operate on an internal 24-hour cycle, known as the circadian rhythm, which influences everything from sleep and wakefulness to metabolism and hormone levels. This intricate biological clock helps us adapt to the daily cycle of light and darkness. However, when this natural rhythm is disrupted, it can contribute to various health problems, including the development and progression of cancers and the physiological decline associated with aging.
Recent scientific advancements have focused on identifying tiny chemical compounds, called small molecules, that can interact with and adjust the core components of this internal clock. These “clock modulators” offer a promising new avenue for therapeutic intervention. By targeting specific proteins and pathways within the circadian system, these molecules can help restore proper timing and function.
In the context of cancer, researchers are investigating whether these clock-modulating compounds can slow tumor growth, improve how well cancer treatments work, and even influence the metabolism and proliferation of cancer cells. For instance, some compounds have shown the ability to inhibit tumor growth in preclinical models by realigning the disrupted metabolic processes often found in cancer cells. Similarly, in aging, strengthening circadian function through these small molecules may lead to improved metabolic health and potentially extend longevity.
While this field, known as chronopharmacology, holds great promise, there are still challenges to overcome, such as understanding potential unintended effects and the complex ways the clock is regulated. Future research aims to develop new therapies that incorporate circadian modulation into strategies for preventing and treating cancer and age-related conditions.
Source: link to paper